GGrantIndex
← Leaderboards

Kenneth M Johnson

University Of Texas Medical Br Galveston

$4,281,805
Attributed
$4,281,805
Total exposure
4
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $420.1K · FY200511
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11

Funding mix

By agency

NIH$4,281,805 · 4

By mechanism

R01$2,879,037 · 2
T32$857,729 · 1
R41$545,039 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Apoptosis

Research focus

ApoptosisLaboratory RatPhencyclidineNeurotoxicologyNeuropharmacologyIn Situ HybridizationImmunocytochemistryNmda ReceptorsNeurotransmitter ReceptorBehavioral /Social Science Research TagPsychopharmacologySchizophreniaBehavior TestMental Disorder ChemotherapyGene Induction /RepressionGenetic RegulationPcp ReceptorNeurochemistryBehavioral Habituation /SensitizationPerinatalDrug MetabolismDrug AbuseDrug Of AbuseCerebral Cortex

Grant awards (20)

Neural and Pharmacological Mechanisms of Abused Drugs$179,590
T32 · FY2011 · DA · contact PI
Neural and Pharmacological Mechanisms of Abused Drugs$170,987
T32 · FY2010 · DA · contact PI
Neurochemical Pharmacology of Phencyclidine$250,557
R01 · FY2009 · DA · contact PI
Neural and Pharmacological Mechanisms of Abused Drugs$169,529
T32 · FY2009 · DA · contact PI
Neural and Pharmacological Mechanisms of Abused Drugs$168,233
T32 · FY2008 · DA · contact PI
Neurochemical Pharmacology of Phencyclidine$250,557
R01 · FY2007 · DA · contact PI
Neural and Pharmacological Mechanisms of Abused Drugs$169,390
T32 · FY2007 · DA · contact PI
Neurochemical Pharmacology of Phencyclidine$258,041
R01 · FY2006 · DA · contact PI
Neurochemical Pharmacology of Phencyclidine$264,250
R01 · FY2005 · DA
Neurochemical Pharmacology of Phencyclidine$259,698
R01 · FY2004 · DA
Perinatal Neurodegeneration and Schizophrenia$223,500
R01 · FY2004 · MH
NET - Selective Ligands for the Treatment of Depression$153,136
R41 · FY2004 · MH
NET - Selective Ligands for the Treatment of Depression$391,903
R41 · FY2003 · MH
Perinatal Neurodegeneration and Schizophrenia$260,750
R01 · FY2003 · MH
NEUROCHEMICAL PHARMACOLOGY OF PHENCYCLIDINE$157,344
R01 · FY2003 · DA
Perinatal Neurodegeneration and Schizophrenia$260,750
R01 · FY2002 · MH
NEUROCHEMICAL PHARMACOLOGY OF PHENCYCLIDINE$152,761
R01 · FY2002 · DA
Perinatal Neurodegeneration and Schizophrenia$248,527
R01 · FY2001 · MH
NEUROCHEMICAL PHARMACOLOGY OF PHENCYCLIDINE$148,310
R01 · FY2001 · DA
NEUROCHEMICAL PHARMACOLOGY OF PHENCYCLIDINE$143,992
R01 · FY2000 · DA